Cas:7146-68-1 p-(p-Chlorophenylsulfonyl)aniline manufacturer & supplier

We serve Chemical Name:p-(p-Chlorophenylsulfonyl)aniline CAS:7146-68-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

p-(p-Chlorophenylsulfonyl)aniline

Chemical Name:p-(p-Chlorophenylsulfonyl)aniline
CAS.NO:7146-68-1
Synonyms:4-(4-chlorophenyl)sulfonylaniline;4-[(4-Chlorophenyl)sulfonyl]aniline;Benzenamine, 4-[(4-chlorophenyl)sulfonyl]-;p-(p-Chlorophenylsulfonyl)aniline
Molecular Formula:C12H10ClNO2S
Molecular Weight:267.731
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:466.4±30.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.635
PSA:68.54000
Exact Mass:267.012085
LogP:2.57

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-(4-chlorophenyl)sulfonylaniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,p-(p-Chlorophenylsulfonyl)aniline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[(4-Chlorophenyl)sulfonyl]aniline Use and application,p-(p-Chlorophenylsulfonyl)aniline technical grade,usp/ep/jp grade.


Related News: According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter. p-(p-Chlorophenylsulfonyl)aniline manufacturer The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said. p-(p-Chlorophenylsulfonyl)aniline supplier In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. p-(p-Chlorophenylsulfonyl)aniline vendor In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. p-(p-Chlorophenylsulfonyl)aniline factory The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said.